The present disclosure relates to chemical compounds that inhibit HP1-mediated heterochromatin formation, pharmaceutical compositions containing such compounds, methods of identifying such compounds, and their use in the treatment of disorders related to heterochromatin formation such as, for example, a disorder of cellular proliferation (e.g., cancer). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
本公开涉及抑制HP1介导的异染色质形成的
化学化合物、含有此类化合物的药物组合物、鉴定此类化合物的方法,以及它们在治疗与异染色质形成有关的疾病(例如细胞增殖障碍(如癌症))中的用途。本摘要旨在作为在特定技术领域进行搜索的扫描工具,并非对本发明的限制。